p.117 抽出テキスト

oxysmal and persistent atrial fibrillation. Circulation 2002; 105: 1077-1081. PMID: 11877358 391. Miyazaki A, Negishi J, Hayama Y, et al. Etiology of atrial fibrillation in patients with complex congenital heart disease - for a better treatment strategy. J Cardiol 2020; 76: 438-445. PMID: 32703716 392. Nakagawa K, Akagi T, Nagase S, et al. Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone. Europace 2019; 21: 1663-1669. PMID: 31410454 393. Waldmann V, Laredo M, Abadir S, et al. Atrial fibrillation in adults with congenital heart disease. Int J Cardiol 2019; 287: 148-154. PMID: 30712848 394. Philip F, Muhammad KI, Agarwal S, et al. Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease. Congenit Heart Dis 2012; 7: 392-399. PMID: 22469422 395. Zeppenfeld K, Schalij MJ, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: Electroanatomic identification of the critical right ventricular isthmus. Circulation 2007; 116: 2241-2252. PMID: 17967973 396. Morwood JG, Triedman JK, Berul CI, et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm 2004; 1: 301-308. PMID: 15851174 397. Sosa E, Scanavacca M, d’Avila A, et al. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 2000; 35: 1442-1449. PMID: 10807445 398. Bordachar P, Marquié C, Pospiech T, et al. Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease. Int J Cardiol 2016; 203: 251-258. PMID: 26519678 399. Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014; 11: e102-e165. PMID: 24814377 400. Reynolds D, Duray GZ, Omar R, et al. Micra Transcatheter Pacing Study Group. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med 2016; 374: 533-541. PMID: 26551877 401. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322-324. PMID: 6991948 402. Bardy GH, Smith WM, Hood MA, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363: 36- 44. PMID: 20463331 403. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656. PMID: 9614255 404. Dawson JD, Sonka M, Blecha MB, et al. Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: The Muscatine Offspring Study. J Am Coll Cardiol 2009; 53: 2273-2279. PMID: 19520251 405. Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J 2014; 35: 725-732. PMID: 23882067 406. Moons P, Van Deyk K, Dedroog D, et al. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil 2006; 13: 612-616. PMID: 16874153 407. Deen JF, Krieger EV, Slee AE, et al. Metabolic Syndrome in Adults With Congenital Heart Disease. J Am Heart Assoc 2016; 5: e001132. PMID: 26873680 408. Lui GK, Rogers IS, Ding VY, et al. Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease. Am J Cardiol 2017; 119: 112-118. PMID: 28247847 409. Afilalo J, Therrien J, Pilote L, et al. Geriatric congenital heart disease: Burden of disease and predictors of mortality. J Am Coll Cardiol 2011; 58: 1509-1515. PMID: 21939837 410. Flanagan MF, Hourihan M, Keane JF. Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol 1991; 68: 403-406. PMID: 1858686 411. Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular ab- normality in cyanotic congenital heart disease. Am J Cardiol 2000; 86: 1198-1204. PMID: 11090791 412. Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and Management of

Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 2017; 136: e348-e392. PMID: 28993401 413. Kowalski R, Lee MGY, Doyle LW, et al. Reduced Aortic Distensibility is Associated With Higher Aorto-Carotid Wave Transmission and Central Aortic Systolic Pressure in Young Adults After Coarctation Repair. J Am Heart Assoc 2019; 8: e011411. PMID: 30929595 414. O’Sullivan J. Late hypertension in patients with repaired aortic coarctation. Curr Hypertens Rep 2014; 16: 421. PMID: 24488485 415. Hager A, Kanz S, Kaemmerer H, et al. Coarctation Long-term Assessment (COALA): Significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg 2007; 134: 738-745. PMID: 17723827 416. 日本高血圧学会.高血圧治療ガイドライン2019.ライフサイエンス出版.2019.https://www.jpnsh.jp/data/jsh2019/JSH2019_hp.pdf 417. Canniffe C, Ou P, Walsh K, et al. Hypertension after repair of aortic coarctation -- A systematic review. Int J Cardiol 2013; 167: 2456- 2461. PMID: 23041096 418. Agarwal S, Jindal I, Balazs A, et al. Catecholamine-Secreting Tumors in Pediatric Patients With Cyanotic Congenital Heart Disease. J Endocr Soc 2019; 3: 2135-2150. PMID: 31687640 419. Sandberg C, Johansson K, Christersson C, et al. Sarcopenia is common in adults with complex congenital heart disease. Int J Cardiol 2019; 296: 57-62. PMID: 31230936 420. Madsen NL, Marino BS, Woo JG, et al. Congenital Heart Disease With and Without Cyanotic Potential and the Long-term Risk of Diabetes Mellitus: A Population-Based Follow-up Study. J Am Heart Assoc 2016; 5: e003076. PMID: 27402234 421. Ohuchi H, Miyamoto Y, Yamamoto M, et al. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J 2009; 158: 30-39. PMID: 19540389 422. Martínez-Quintana E, Rodríguez-González F, Nieto-Lago V, et al. Serum glucose and lipid levels in adult congenital heart disease patients. Metabolism 2010; 59: 1642-1648. PMID: 20423747 423. Ohuchi H, Yasuda K, Ono S, et al. Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease. Int J Cardiol 2014; 174: 306-312. PMID: 24780541 424. Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down’s syndrome: prevalence, management and diabetic complications. Diabet Med 1998; 15: 160-163. PMID: 9507919 425. Bhatt AB, Foster E, Kuehl K, et al. Congenital heart disease in the older adult: A scientific statement from the American Heart Association. Circulation 2015; 131: 1884-1931. PMID: 25896865 426. 日本糖尿病学会.糖尿病診療ガイドライン2019.http://www.jds. or.jp/modules/publication/index.php?content_id=4 427. Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation 2019; 140: e294-e324. PMID: 31167558 428. Grant PJ, Cosentino F. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the ‘Ten Commandments’ of the 2019 Guidelines are discussed by Professor Peter J. Grant and Professor Francesco Cosentino, the Task Force chairmen. Eur Heart J 2019; 40: 3215-3217. PMID: 31608951 429. Moon JR, Song J, Huh J, et al. Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease. Korean Circ J 2015; 45: 416-423. PMID: 26413110 430. Martínez-Quintana E, Rodríguez-González F. Lipoprotein(a) concentrations in adult congenital heart disease patients. Congenit Heart Dis 2014; 9: 63-68. PMID: 23701863 431. Niwa K. Metabolic Syndrome in Adult Congenital Heart Disease. Korean Circ J 2019; 49: 691-708. PMID: 31347322 432. Fyfe A, Perloff JK, Niwa K, et al. Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol 2005; 96: 283-290. PMID: 16018858 433. 日本動脈硬化学会.動脈硬化性疾患予防ガイドライン2017年版.

2017 434. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines

for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipi-